Beatriz Gros

Appearances

MULTIPLE INFLIXIMAB BIOSIMILAR SWITCHES APPEAR TO BE SAFE AND EFFECTIVE IN A REAL-WORLD INFLAMMATORY BOWEL DISEASE COHORT
Date
May 7, 2023
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Presenter
Beatriz Gros
Speakers
Nikolas Plevris
Nathan Constantine-Cooke
Mathew Lyons
Claire O'Hare
Colin Noble
Ian Arnott
Gareth-Rhys Jones
Charlie Lees
Lauranne Derikx
HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY
Date
May 7, 2023
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Presenter
Charlie Lees
Speakers
Beatriz Gros
Janet Kyle
Nikolas Plevris
Lauranne Derikx
Nathan Constantine-Cooke
Gareth Jones
Phillip Jenkinson
Spyros Siakavellas
Lee Murphy
Nicholas Kennedy
Daniel Gaya
Lisa Derr
Graham Horgan
Christopher Weir
Alex Johnstone
Linda Williams